BioCentury
ARTICLE | Company News

Novo Nordisk sales and marketing update

February 10, 2014 8:00 AM UTC

Novo Nordisk disclosed in its 2013 earnings that in January it launched NovoEight turoctocog alfa in Germany to treat and prevent bleeding in hemophilia A patients. Novo Nordisk plans to launch the t...